Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression

被引:2
作者
Behrens, P [1 ]
Rothe, M [1 ]
Florin, A [1 ]
Wellmann, A [1 ]
Wernert, N [1 ]
机构
[1] Univ Bonn, Inst Pathol, D-53105 Bonn, Germany
关键词
ovarian cancer; invasion; metalloproteinases; Ets-1;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The invasive potential of serous epithelial ovarian tumors is the main factor determining their biological behaviour. In contrast to invasive serous ovarian carcinomas serous borderline tumors generally present without stromal invasion and without or non-invading peritoneal implants. Little is known about the reasons underlying these differences. In the present study we found that two matrix-degrading metalloproteinases, collagenases 1 and 4 (MMPs 1 and 9), as well as the Ets-1 transcription factor are expressed at very Low levels in serous benign cystadenomas, upregulated in the fibroblastic stroma, but not in the epithelium of borderline tumors and most strongly expressed in both stromal and epithelial tumor cells of serous invasive carcinomas. Since expression of Ets-1 and of MMPs 1 and 9 are topographically related, a transcriptional regulation of both proteases by Ets-l is suggested. Upregulation of MMPs 1 and 9 within fibroblastic stromal cells of borderline tumors might be related to matrix remodelling and additional expression of both enzymes by the neoplastic cells of invasive carcinomas could then allow invasive propagation. The different expression patterns might supports the view, that no transition of serous borderline tumors into invasive carcinomas occurs.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 66 条
[1]  
AbuJawdeh GM, 1996, LAB INVEST, V74, P1105
[2]   MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts [J].
Afzal, S ;
Lalani, EN ;
Poulsom, R ;
Stubbs, A ;
Rowlinson, G ;
Sato, H ;
Seiki, M ;
Stamp, GWH .
HUMAN PATHOLOGY, 1998, 29 (02) :155-165
[3]  
Afzal S, 1996, LAB INVEST, V74, P406
[4]  
Alvarez AA, 1999, CLIN CANCER RES, V5, P587
[5]   K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary [J].
Alvarez, AA ;
Moore, WF ;
Robboy, SJ ;
Bentley, RC ;
Gumbs, C ;
Futreal, PA ;
Berchuck, A .
GYNECOLOGIC ONCOLOGY, 2001, 80 (02) :201-206
[6]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[7]  
2-L
[8]   OVARIAN SURFACE EPITHELIAL-STROMAL TUMORS [J].
BELL, DA .
HUMAN PATHOLOGY, 1991, 22 (08) :750-762
[9]   Tissue inhibitors of matrix metalloproteinases in cancer [J].
Blavier, L ;
Henriet, P ;
Imren, S ;
DeClerck, YA .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :108-119
[10]  
BOLON I, 1995, AM J PATHOL, V147, P1298